What is Nurix Therapeutics, Inc.'s R&D?

Nurix Therapeutics, Inc. (NRIX) reported R&D of $84.14M in Q4 2025.

How has Nurix Therapeutics, Inc.'s R&D changed year-over-year?

Nurix Therapeutics, Inc.'s R&D increased by 20.8% year-over-year, from $69.66M to $84.14M.

What is the long-term trend for Nurix Therapeutics, Inc.'s R&D?

Over 4 years (2021 to 2025), Nurix Therapeutics, Inc.'s R&D has grown at a 28.4% compound annual growth rate (CAGR), from $116.43M to $316.9M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Nurix Therapeutics, Inc. NRIX R&D

R&D at other companies

Kymera TherapeuticsKYMR

$98.16M+22.3%

Monte Rosa Therapeutics, Inc.GLUE

$44.07M+36.9%

Stoke Therapeutics, Inc.STOK

$39.67M+21.4%

Viridian Therapeutics, Inc.VRDN

$77.63M+1.0%

Nuvation BioNUVB

$35.05M+42.5%

Ultragenyx PharmaceuticalRARE

$187M+12.7%

Other financials

Income statement

See full

Revenue$6.3M-66.1%

Operating income-$92.5M-47.1%

Net income-$87.2M-54.7%

EPS (diluted)-$0.79-17.9%

Balance sheet

See full

Cash & equivalents$72.2M-6.1%

Total debt$58.7M+120%

Total equity$480.9M0.0%

Total assets$636.1M+3.4%

Cash flow

See full

Operating cash flow-$71.9M-17.7%

CapEx$1.0M-70.0%

Free cash flow-$73.0M-13.0%

Valuation

See full

Market cap$1.95B+40.1%

Enterprise value$1.94B+45.1%

P/S27.2×+2.5×

Profitability

See full

Operating margin-439.3%+35.3pp

Net margin-411.4%+52.7pp

FCF margin-378.7%+24.1pp

Returns & leverage

See full

Return on equity-61.4%-2.5pp

Debt / equity0.1×+0.1×

Current ratio6×-0.3×

Where this comes from

Reported directly by Nurix Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nurix Therapeutics, Inc.'s r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nurix Therapeutics, Inc.'s R&D?: Nurix Therapeutics, Inc. (NRIX) reported R&D of $84.14M in Q4 2025.
How has Nurix Therapeutics, Inc.'s R&D changed year-over-year?: Nurix Therapeutics, Inc.'s R&D increased by 20.8% year-over-year, from $69.66M to $84.14M.
What is the long-term trend for Nurix Therapeutics, Inc.'s R&D?: Over 4 years (2021 to 2025), Nurix Therapeutics, Inc.'s R&D has grown at a 28.4% compound annual growth rate (CAGR), from $116.43M to $316.9M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.